HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pro-remodeling effect of autoantibody against β1-adrenoceptor on cardiomyocytes involves T cells dysfunction under the pathological condition of heart failure.

Abstract
Autoantibody against β1-adrenoceptor (β1-AA) has been shown to be closely linked to the aggravation of heart failure. Removal of β1-AA remarkably attenuated patients' cardiac dysfunction. We found that β1-AA induced rat heart failure with increased CD4+ T cells. However, whether or not β1-AA interacts with T cells isolated from heart failure patients remains unknown. Twenty-one β1-AA-negative heart failure patients were divided into those taking β-adrenergic blocker and those not. The effects of β1-AA monoclonal antibodies (β1-AAmAb) on T cells proliferation were detected using the CCK-8 assay. IFN-γ and IL-4 production by human T cells were measured by after the administration of β1-AAmAb. The levels of cardiomyocyte apoptosis and hypertrophy were detected after co-cultured with the supernatant of T cells pre-stimulated by β1-AAmAb. It was found that β1-AAmAb promoted T cell proliferation via the β1-AR/cAMP/PKA pathway in patients who not take β-blocker. β1-AAmAb inhibited the characteristic cytokine secretion of Th1, IFN-γ, but had no significant effect on the Th2 cytokine IL-4. Supernatant resulted from the T cells pre-treated with β1-AAmAb induced cardiomyocytes remodeling, as evidenced by increased levels of cardiomyocytes apoptosis and hypertrophy. We propose that heart failure is likely to be an interference factor for Th-mediated immunity, and the presence of β1-AAmAb may aggravate this effect and deteriorate concomitant inflammatory injury in cardiomyocytes, partially via β1-AR/cAMP/PKA pathway.
AuthorsYunhui Du, Shihan Zhang, Wenjing Hao, Wenli Xu, Li Yan, Huirong Liu
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 510 Issue 1 Pg. 163-170 (02 26 2019) ISSN: 1090-2104 [Electronic] United States
PMID30678811 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Adrenergic beta-1 Receptor Antagonists
  • Autoantibodies
  • Receptors, Adrenergic, beta-1
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
Topics
  • Adrenergic beta-1 Receptor Antagonists (administration & dosage, therapeutic use)
  • Autoantibodies (pharmacology)
  • Cell Proliferation (drug effects)
  • Coculture Techniques
  • Cyclic AMP (metabolism)
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Heart Failure (immunology, pathology)
  • Humans
  • Myocytes, Cardiac (drug effects)
  • Receptors, Adrenergic, beta-1 (immunology)
  • T-Lymphocytes (pathology)
  • T-Lymphocytes, Helper-Inducer (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: